Appendix G to Exclusive Distribution and Licensing Agreement between Resdevco Ltd. and Wize Pharma Ltd. (LO2A Eye Drops)
Resdevco Ltd. grants Wize Pharma Ltd. (and Ocu Wize Ltd.) the right to use all patents and trade names related to LO2A unit dose eye drops in Israel and Ukraine, as long as the Exclusive Distribution and Licensing Agreement remains valid for those territories. This declaration confirms Wize's rights to use the intellectual property for the duration of the agreement.
Exhibit 10.19
Appendix G. to the Exclusive Distribution and Licensing Agreement, dated May 1, 2015
July 20, 2017
Resdevco Ltd. hereby declares that all its patents and trade names related to the LO2A unit dose eye drops may be used by Wize Phanna Ltd./ Ocu Wize Ltd. in the territories to which the Exclusive Distribution and Licensing Agreement, dated May 1, 2015 is extended (at present Israel and the Ukraine) as long as the contract for those territories is valid
Sincerely,
| Wize Pharma Ltd. | Resdevco Ltd. | |||
| By: | /s/ Or Eisenberg | By: | /s/ Prof. S. Dikstein | |
| Name: | Or Eisenberg | Name: | Prof. S. Dikstein | |
| Title: | CFO & CEO | Title: | CEO | |
